352770 — Celestra Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- KR₩14bn
- KR₩44bn
- KR₩9bn
Annual income statement for Celestra, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 9,820 | 55,426 | 23,083 | 11,408 | 8,502 |
| Cost of Revenue | |||||
| Gross Profit | 1,790 | 37,413 | 8,238 | 289 | -1,182 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 22,074 | 32,499 | 33,858 | 47,248 | 53,837 |
| Operating Profit | -12,254 | 22,927 | -10,775 | -35,840 | -45,335 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13,146 | 24,819 | -10,122 | -42,431 | -47,089 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -13,147 | 15,853 | -10,234 | -42,399 | -47,055 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -13,147 | 15,853 | -10,177 | -42,257 | -46,925 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -13,147 | 14,204 | -10,177 | -42,257 | -46,925 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -714 | 542 | -430 | -1,538 | -983 |
| Dividends per Share |